Literature DB >> 1906036

Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing.

J G Patton1, S A Mayer, P Tempst, B Nadal-Ginard.   

Abstract

alpha-Tropomyosin exons 2 and 3 are spliced in a mutually exclusive manner. Exon 3 is included as the default exon in the mRNA of most cell types, whereas exon 2 is only included in the mRNA of smooth muscle cells. The primary determinant for the default selection of exon 3 is the branchpoint/polypyrimidine tract. This element upstream of exon 3 clearly and effectively outcompetes the corresponding element upstream of exon 2. To identify trans-acting factors that bind to this important cis element, we used UV cross-linking to identify a 57-kD protein whose binding characteristics directly correlate with 3'-splice-site selection in cis-competition splicing assays. This protein appears to be identical to polypyrimidine tract-binding protein. In this report we have used oligonucleotides derived from peptide sequences to isolate and sequence cDNA clones encoding this 57.2-kD protein. The primary sequence reveals a novel protein with significant homology to other RNA-binding proteins. Expression of the mRNA is detected in all tissues and cells examined, although its levels exhibit tissue-specific and developmental regulation. Using a biochemical complementation assay, we have found that this protein, along with a 100-kD protein, exists as part of a large complex that is required to rescue splicing from depleted nuclear extracts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906036     DOI: 10.1101/gad.5.7.1237

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  155 in total

1.  A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

Authors:  T Chen; F M Boisvert; D P Bazett-Jones; S Richard
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

Authors:  J Côté; S Dupuis; J Y Wu
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

4.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Combinatorial control of a neuron-specific exon.

Authors:  E F Modafferi; D L Black
Journal:  RNA       Date:  1999-05       Impact factor: 4.942

Review 6.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  A novel conserved RNA-binding domain protein, RBD-1, is essential for ribosome biogenesis.

Authors:  Petra Björk; Göran Baurén; ShaoBo Jin; Yong-Guang Tong; Thomas R Bürglin; Ulf Hellman; Lars Wieslander
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

8.  PSF and p54nrb bind a conserved stem in U5 snRNA.

Authors:  Rui Peng; Billy T Dye; Ismael Pérez; Daron C Barnard; Amanda B Thompson; James G Patton
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

9.  The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms.

Authors:  A Moreira; Y Takagaki; S Brackenridge; M Wollerton; J L Manley; N J Proudfoot
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

10.  Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.

Authors:  A C Black; J Luo; C Watanabe; S Chun; A Bakker; J K Fraser; J P Morgan; J D Rosenblatt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.